RLMD Latest Press Releases

-- August 6, 2026 --

Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- July 28, 2026 --

Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer Globe Newswire 8:30 AM

-- July 16, 2026 --

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 Globe Newswire 7:05 AM

-- June 29, 2026 --

Relmada Therapeutics Joins Russell 2000 and Russell 3000 Indexes Globe Newswire 7:00 AM

-- June 11, 2026 --

Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program Globe Newswire 7:00 AM

-- May 28, 2026 --

Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference Globe Newswire 7:00 AM

-- May 12, 2026 --

Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- May 6, 2026 --

Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 Globe Newswire 7:00 AM

-- May 5, 2026 --

Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026 Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software